← Open Payments lookup

LINDSEY KELLEY: Open Payments

NPI 1134747850 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$432 in 17 payments from 10 companies in 2025. Trend: 2023 $431 · 2024 $636 · 2025 $432

Food & beverage: $433
CompanyPaymentsAmount
Novo Nordisk Inc3$146
ABBVIE INC.4$87
Axsome Therapeutics, Inc.2$44
Astellas Pharma US Inc2$34
Lilly USA, LLC1$24
Ardelyx, Inc.1$22
GlaxoSmithKline, LLC.1$21
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$20
Otsuka America Pharmaceutical, Inc.1$18
Corcept Therapeutics1$17

Products named: Ozempic, QULIPTA, Auvelity, Veozah, ZEPBOUND, SKYRIZI, IBSRELA, TRELEGY ELLIPTA.

Industry payments across LA — which companies pay providers there.